Upcoming Events

September 9, 2010

TOPIC:
Miscibility Estimation of Poorly Soluble Drugs in Polymers for the Preparation of Solid Solutions with Melt Extrusion Technology

SPEAKER:
Firouz Asgarzadeh
Principal Scientist, Pharma Polymers, Evonik-Degussa Corporation

LOCATION:
Lai Lai Garden (610/277-5988)
1144 Dekalb Pike
Blue Bell, PA 19422

Details

Previous Events

• May 13, 2010
  Realities of Drug Discovery and Development in Today's Environment
  Dr. Magid Abu-Gharbia, Founding Director of the Moudler Center for Drug Discovery, Temple University School of Pharmacy
  


• April 8, 2010
  Colorectal Cancer Chemoprevention: Conjugation of Dietary Phytochemicals
  Dr. Swati Nagar, Temple University School of Pharmacy
  
  
• March 11, 2010
  Student Poster Night & Presentation
  Emerging Bioequivalence Issues in Inhaled Products
  Richard N. Dalby, Ph.D., University of Maryland School of Pharmacy
  
  
• February 11, 2010
  Liquid Dispensing Technologies (LDT) – A Custom Manufacturing Technology for Highly Potent, Low Dose Oral Tablets
  Allan Clarke, GlaxoSmithKline
  
  
• January 14, 2010
  Formulation Flexibility & Excipient Functionality in QbD
  Dr. Brian AC Carlin, Director Open Innovation, FMC BioPolymer

• December 10, 2009
  Business Card Exchange
  
  
• November 19, 2009
  Recent Advances in Continuous Film Coating Technology
  Mr. Charlie Cunningham, Colorcon
  
  
• October 8, 2009
  Pharmaceutical Polymers for Hot Melt Extrusion - A Review of their Function and Application
  Dr. Nigel Langley
  
  
• May 14, 2009
  Development of Microparticulate Drug Delivery Systems for Clinical Trials
  Patrick P. DeLuca, PhD, President, American Association of Pharmaceutical Scientists (AAPS), Professor, College of Pharmacy, University of Kentucky
  
  
• April 9, 2009
  Nanotechnology-based Drug Delivery: The First Step Towards Individualized Medicine?
  Patrick J. Sinko, Ph.D., RPh, Parke-Davis Professor of Pharmaceutics and Drug Delivery, Associate Vice President for Research, Rutgers University
  
  
• March 6, 2009
  Joseph B. Schwartz Memorial Symposium: Advances in Industrial Pharmacy
  Sponsored by the Philadelphia College of Pharmacy at University of the Sciences and the Philadelphia Pharmaceutical Forum
  Keynote speaker Robert E. O'Connor, Ph.D., vice president of product support at Cordis, a Johnson & Johnson company
  
  
• February 12, 2009
  Convergent Technologies and the Future of the Pharmaceutical Industry
  Theodore J. Torphy, Ph.D., Chief Scientific Officer & Head, External Research & Early Development, Johnson & Johnson Pharmaceuticals Group
  
  
• January 8, 2009
  The Future Pharmaceutical Scientists
  Karen Habucky, Ph.D.
  
  

• October 9, 2008
  Current challenges in dissolution testing including the role of QBD
  Vivian A. Gray, V. A. Gray Consulting, Inc., Hockessin, DE
  
  
• September 11, 2008
  A Novel Process to Replace Most Granulation Processes
  Dr. Ismat Ullah, Bristol-Myers Squibb Co.
  
  
• May 8, 2008
  Using Gamma Scintigraphy to Achieve Optimal Oral Drug Delivery in Early Drug Development
  John McDermott, Pharmaceutical Profiles
  
  
• April 10, 2008
  Tablet Film Coating and the Application of "Quality by Design" Initiatives
  Dr. Stuart C. Porter, International Specialty Products (ISP)
  
  
• March 13th, 2008
  Lipid Based Drug Delivery Systems and Enhanced Bioavailability Mechanisms and Potential
  Dr. Paul M. Bummer , College of Pharmacy, University of Kentucky
  
  
• February 14, 2008
  Next Generation Drug-device Combination Products
  Dr. Jonathon Zhao, Cordis Corporation, A Johnson and Johnson Company
  
  
• January 10, 2008
  Pharmacogenomics: a new approach to drug discovery and treatment
  Dr. Evgeny Krynetskiy, Temple University and the Jayne Haines Center for Pharmacogenomics and Drug Safety
  
  

• November 8, 2007
  Technology Transfer by Design: Using Lean Six Sigma and Quality by Design to Improve the Process
  Ronald D. Snee and William J. Reilly, Jr., Tunnell Consulting

• October 11, 2007
  Nanosizing for Oral Drug Delivery – Biopharmaceutical and Formulation Aspects
  Dr. Filippos Kesisoglou and Dr. Sunny Panmai, Merck Research Laboratories

• September 13, 2007
  Lipid Based Self Micro-Emulsifying Systems (SMEDDS): Applications, Excipient Selection, Formulation, and Characterization
  Jasmine Musakhanian, Gattefossé USA

• May 10, 2007
  A Pediatricians Perspective of Pharmacotherapeutic Trial Philosophy and Processes: Children as Subjects
  Dr. Andrew Mulberg, Mature Products Therapeutic Area

• April 8, 2007
  Making our Data Patterns Visible
  Dr. Anil Mennon, Sanofi-Aventis

• March 8, 2007
  A Pharma View of the CYPHER® Sirolimus-eluting Coronary Stent
  Dr. Cynthia Maryanoff, Cordis Corporation, J&J Company

• February 8, 2007
  Pseudolatex Coatings in Controlled Release
  Dr. Brian AC Carlin MRPharmS, MRSC CChem, FMC BioPolymer

• January 11, 2007
  Soluble Macromolecular Conjugates for Passive Tumor Targeting
  Dr. Clyde Ofner III, University of the Sciences in Philadelphia